WHO BENEFITS MOST FROM RHINAER®?

TREATMENT FOR CHRONIC RHINITIS:

RhinAer Patient Selection

Approximately 30% of the U.S. population experiences chronic rhinitis, presenting with symptoms such as rhinorrhea, congestion, post-nasal drip, itching, sneezing, and coughing.¹ The etiology of chronic rhinitis can be allergic, non-allergic, or a combination of both.²

RhinAer may offer significant symptom relief to:

Patients with moderate to severe chronic rhinorrhea, post-nasal drip, congestion, and/or chronic throat clearing

Patients with non-allergic chronic rhinitis

Patients undergoing allergy immunotherapy with persistent drainage

Post-FESS patients with uncontrolled rhinitis

Consider incorporating the Total Nasal Symptom Score (TNSS) to assess the severity of a patient’s chronic rhinitis.

Current Treatment Options

Medical Therapy

Many medically managed chronic rhinitis sufferers are unresponsive/unhappy
Requires frequent daily use for short-term symptom relief
Can result in tolerance and “rebound,” with short and long-term side effects

Traditional Surgery

Vidian and posterior nasal nerve neurectomy are the last resort in severe cases
While efficacious, they are not widely adopted due to their invasive nature and side effects
Turbinate surgery treats congestion, not underlying issue

The RhinAer Advantage

Sixty-two percent of chronic rhinitis patients experience severe symptoms, with 90% expressing interest in a non-invasive treatment option.³ RhinAer offers a comprehensive solution targeting common contributors to chronic rhinitis. RhinAer patients benefit from:

An incisionless procedure

that can be performed under local anesthesia

Minimal downtime

enabling a quick return to normal activities

Significant symptom improvement

within 4-6 weeks and long-lasting results

SHARED DECISION MAKING:

Choosing the Right Treatment Approach

When discussing treatment options with your chronic rhinitis patients, it’s important to consider their needs and preferences alongside the severity of their symptoms and underlying causes.

74% of patients with medically refractory chronic rhinitis opted for a procedural intervention rather than ongoing medical management⁴
72% of patients preferred undergoing the procedure in an office setting⁴

Treat Your Patients with RhinAer!

Request a Demo

WEB1323-26.A

Disclaimer

The RhinAer^® Stylus is indicated for use in otorhinolaryngology (ENT) surgery for the destruction of soft tissue in the nasal airway, including in posterior nasal nerve regions in patients with chronic rhinitis.

Specific indications, contraindications, warnings, precautions, and safety information exist for these products. Aerin Medical relies on the physician to determine, assess and communicate to each patient all foreseeable risks of the procedure. A physician must always refer to the package insert, product label and/or instructions for use before using any of Aerin Medical’s products. Rx only.

References:

Roland LT, Wise SK, Wang H, Zhang P, Mehta C, Levy JM. The cost of rhinitis in the United States: a national insurance claims analysis. Int Forum Allergy Rhinol. 2021 May;11(5):946-948.
Scarupa MD, Kaliner MA. Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations. World Allergy Organ J. 2009 Mar;2(3):20-5.
Data on file with Aerin Medical.
Payne SC, Stolovitzky P, Mehendale N, Matheny K, Brown W, Rieder A, Liepert D, Tseng E, Gould A, Powell S, Van Himbergen D, Karanfilov B, Harfe D, England L, Melroy C. Medical therapy versus sinus surgery by using balloon sinus dilation technology: A prospective multicenter study. Am J Rhinol Allergy. 2016 Jul;30(4):279-86.